Publication: A systematic review of disease prevalence, health-related quality of life, and economic outcomes associated with Friedreich’s Ataxia
This systematic review, published in Current Medical Research and Opinion, explores current understanding of the prevalence, health-related quality of life (HRQoL) and economic burden of Friedreich’s ataxia
Discover the prevalence of Friedreich’s ataxia, a rare progressive neurodegenerative genetic condition
Explore different assessments and their outcomes on HRQoL and the importance of tracking these changes over time
Evaluate the economic impact of direct and indirect costs on patients with Friedreich’s ataxia and their caregivers
Review remaining unmet needs and knowledge gaps, including understanding caregiver HRQoL
Buesch K and Zhang R. Curr Med Res Opin. 2022;38(10):1739–1749
Once registered, you will be able to view the abstract and be provided with the DOI links for this publication.
Register now to unlock the content
Register now to access the content on this page
Already registered?
If not, register below
MED-ALL-FA-2300006 | November 2023
Sign in or register to access exclusive content on this site
Register here to access the content on the site MED-ALL-CORP-2200029 | October 2023
You are now leaving MEDhub, a website provided by PTC Therapeutics. This link will take you to a website to which our Privacy Statement and our Terms and Conditions do not apply.
We encourage you to read the Privacy Policy and the Terms and Conditions of every website you visit. PTC Therapeutics does not endorse and/or influence the content found on websites not owned/operated by PTC Therapeutics.
The content you are trying to access is not currently available.
We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available, register now.